Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor
Magdalena M. Bajer(Goethe University Frankfurt), Bernhard Brüne(Goethe University Frankfurt), Kirk R. Gustafson(Target (United States)), Johanna S. Blees(Goethe University Frankfurt), Heidi R. Bokesch(Frederick National Laboratory for Cancer Research), James B. McMahon(National Cancer Institute), Nancy H. Colburn(Gene Therapy Laboratory), Curtis J. Henrich(Frederick National Laboratory for Cancer Research), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Thilo F. Brauß(Goethe University Frankfurt), Tobias Schmid(Goethe University Frankfurt), Hanyong Chen(University of Minnesota Medical Center), Michael M. Kunze(Goethe University Frankfurt), Ricardo M. Biondi(Universidad de Buenos Aires)
Cited by 17
Related Papers
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
|Oncogene|2007|1.9k
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
|Science|2006|712
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
|Oncogene|2008|711
Mitochondrial composition and function under the control of hypoxia
|Redox Biology|2017|635
The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation
|Molecular and Cellular Biology|2002|490